UBS Group
PSIL icon

UBS Group’s AdvisorShares Psychedelics ETF PSIL Stock Holding History

UBS Group’s Portfolio PSIL Stock Details PSIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-250
Closed -$4.22K – 10915
2026
Q1 		$4.22K Buy
250
+38
+18% +$645 ﹤0.01% 8962
2025
Q4 		$3.64K Buy
212
+177
+506% +$3.35K ﹤0.01% 8978
2025
Q3 		$664 Sell
35
-2,049
-98% -$34.2K ﹤0.01% 9583
2025
Q2 		$28.9K Sell
2,084
-327
-14% -$4.06K ﹤0.01% 8190
2025
Q1 		$28.1K Buy
2,411
+2,285
+1,813% +$29.6K ﹤0.01% 7994
2024
Q4 		$1.38K Sell
126
-2,127
-94% -$23.9K ﹤0.01% 9251
2024
Q3 		$17.2K Buy
2,253
+1,367
+154% +$12.6K ﹤0.01% 7454
2024
Q2 		$8.65K Buy
+886
New +$10.9K ﹤0.01% 7792
2023
Q3 		– Sell
-1
Closed -$17 – 9860
2023
Q2 		$17 Sell
1
-21
-95% -$376 ﹤0.01% 8702
2023
Q1 		$409 Sell
22
-7
-24% -$143 ﹤0.01% 9048
2022
Q4 		$532 Buy
+29
New +$682 ﹤0.01% 10147
2022
Q3 		– Hold
0
– – – 10799
2022
Q2 		– Hold
0
– – – 10788

Other funds holding PSIL

CBU
CIBC Bancorp USA Chicago, Illinois $82.3B AUM
Belvedere Trading
Belvedere Trading Chicago, Illinois $87.6B AUM 131.08% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $171B AUM 85% 1-Year Est. Return
VWM
Vigilare Wealth Management Scottsdale, Arizona $326M AUM 21.58% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.12B AUM 34.21% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
PS
Planning Strategies Lancaster, Pennsylvania $160M AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
APFP
Action Point Financial Planning Grand Rapids, Michigan $984M AUM

UBS Group's PSIL Position: Q2 2026 in Review

UBS Group sold out of AdvisorShares Psychedelics ETF (PSIL) in Q2 2026, closing a stake of 250 shares — an estimated $4.22K sold.

UBS Group first reported a position in PSIL in Q4 2022 and held it in 11 quarters. The position peaked at $28.9K in Q2 2025. 19 funds tracked by Wall St. Rank hold PSIL as of Q2 2026.

  • UBS Group reported no remaining AdvisorShares Psychedelics ETF position as of Q2 2026 after selling out during the quarter.
  • UBS Group sold 250 AdvisorShares Psychedelics ETF shares in Q2 2026, an estimated $4.22K.
  • UBS Group first reported a position in AdvisorShares Psychedelics ETF in Q4 2022 and held it in 11 quarters.
  • UBS Group's AdvisorShares Psychedelics ETF position peaked at $28.9K in Q2 2025.
  • 19 funds tracked by Wall St. Rank held AdvisorShares Psychedelics ETF as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.